Dipotassium Glycyrrhizinate on Melanoma Cell Line: Inhibition of Cerebral Metastases Formation by Targeting NF-kB Genes-Mediating MicroRNA-4443 and MicroRNA-3620-Dipotassium Glycyrrhizinate Effect on Melanoma.

CD209 Dipotassium Glycyrrhizinate NF-kB pathway inhibition TCN genes modulation anti-migratory effect melanoma cell line SK-MEL-28 miR-4443 and miR-3620

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Jun 2022
Historique:
received: 25 04 2022
revised: 19 05 2022
accepted: 21 05 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Glycyrrhizic acid (GA), a natural compound isolated from licorice (Glycyrrhiza glabra), has exhibited anti-inflammatory and anti-tumor effects in vitro. Dipotassium glycyrrhizinate (DPG), a dipotassium salt of GA, also has shown an anti-tumor effect on glioblastoma cell lines, U87MG and T98G. The study investigated the DPG effects in the melanoma cell line (SK-MEL-28). MTT assay demonstrated that the viability of the cells was significantly decreased in a time- and dose-dependent manner after DPG (IC50 = 36 mM; 24 h). DNA fragmentation suggested that DPG (IC50) induced cellular apoptosis, which was confirmed by a significant number of TUNEL-positive cells (p-value = 0.048) and by PARP-1 [0.55 vs. 1.02 arbitrary units (AUs), p-value = 0.001], BAX (1.91 vs. 1.05 AUs, p-value = 0.09), and BCL-2 (0.51 vs. 1.07 AUs, p-value = 0.0018) mRNA compared to control cells. The proliferation and wound-healing assays showed an anti-proliferative effect on DPG-IC50-treated cells, also indicating an inhibitory effect on cell migration (p-values < 0.001). Moreover, it was observed that DPG promoted a 100% reduction in melanospheres formation (p-value = 0.008). Our previous microRNAs (miRs) global analysis has revealed that DPG might increase miR-4443 and miR-3620 expression levels. Thus, qPCR showed that after DPG treatment, SK-MEL-28 cells presented significantly high miR-4443 (1.77 vs. 1.04 AUs, p-value = 0.02) and miR-3620 (2.30 vs. 1.00 AUs, p-value = 0.01) expression compared to control cells, which are predicted to target the NF-kB, CD209 and TNC genes, respectively. Both genes are responsible for cell attachment and migration, and qPCR revealed significantly decreased CD209 (1.01 vs. 0.54 AUs, p-value = 0.018) and TNC (1.00 vs. 0.31 AUs, p-value = 2.38 × 10−6) mRNA expression levels after DPG compared to untreated cells. Furthermore, the migration of SK-MEL-28 cells stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA) was attenuated by adding DPG by wound-healing assay (48 h: p-value = 0.004; 72 h: p-value = 7.0 × 10−4). In addition, the MMP-9 expression level was inhibited by DPG in melanoma cells stimulated by TPA and compared to TPA-treated cells (3.56 vs. 0.99 AUs, p-value = 0.0016) after 24 h of treatment. Our results suggested that DPG has an apoptotic, anti-proliferative, and anti-migratory effect on SK-MEL-28 cells. DPG was also able to inhibit cancer stem-like cells that may cause cerebral tumor formation.

Identifiants

pubmed: 35806253
pii: ijms23137251
doi: 10.3390/ijms23137251
pmc: PMC9266887
pii:
doi:

Substances chimiques

MIRN-4443 microRNA, human 0
MicroRNAs 0
NF-kappa B 0
RNA, Messenger 0
Glycyrrhizic Acid 6FO62043WK

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : São Paulo Research Foundation
ID : 2015/03870-1
Organisme : São Paulo Research Foundation
ID : Scholarships# 2018/05930-0
Organisme : Coordenação de Aperfeicoamento de Pessoal de Nível Superior
ID : Scholarships#88887.464813/2019-00

Références

Inflammation. 2001 Jun;25(3):157-63
pubmed: 11403206
Oncotarget. 2016 May 3;7(18):25162-79
pubmed: 27036017
Am J Physiol Cell Physiol. 2001 Oct;281(4):C1096-105
pubmed: 11546645
Food Chem Toxicol. 2015 Apr;78:33-41
pubmed: 25656647
J Coll Physicians Surg Pak. 2015 Sep;25(9):680-8
pubmed: 26374366
Int J Mol Med. 2005 Aug;16(2):233-6
pubmed: 16012754
Oncol Rep. 2008 Dec;20(6):1387-92
pubmed: 19020719
Arch Toxicol. 2013 May;87(5):857-69
pubmed: 23288142
Cell Adh Migr. 2015;9(1-2):125-30
pubmed: 25482624
Mol Med. 2003 May-Aug;9(5-8):143-53
pubmed: 14571322
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Biol Chem. 1999 Jul-Aug;380(7-8):953-9
pubmed: 10494847
Front Cell Neurosci. 2019 May 28;13:216
pubmed: 31191251
Oncogene. 2007 Mar 22;26(13):1954-8
pubmed: 17001349
Cell. 2000 Mar 3;100(5):575-85
pubmed: 10721994
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3878-83
pubmed: 11891271
BMC Cancer. 2018 Jun 22;18(1):675
pubmed: 29929490
Biochem Biophys Res Commun. 2009 Oct 2;387(4):646-50
pubmed: 19619515
Neurol Clin. 2018 Aug;36(3):557-577
pubmed: 30072071
Int J Mol Med. 2006 Feb;17(2):215-9
pubmed: 16391818
Trends Pharmacol Sci. 2007 Nov;28(11):556-60
pubmed: 17950909
Cancer. 2011 Apr 15;117(8):1687-96
pubmed: 20960525
Pigment Cell Res. 2004 Apr;17(2):173-80
pubmed: 15016307
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
Melanoma Res. 2012 Jun;22(3):215-24
pubmed: 22495670
BMC Cancer. 2018 Apr 27;18(1):490
pubmed: 29703161
J Clin Oncol. 2004 Feb 15;22(4):617-23
pubmed: 14966085
PLoS One. 2015 Aug 26;10(8):e0136669
pubmed: 26309255
J Leukoc Biol. 2002 Jun;71(6):921-31
pubmed: 12050176
Mol Cell. 2007 Jan 26;25(2):297-308
pubmed: 17244536
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Cell Physiol. 2010 Nov;225(2):472-81
pubmed: 20458747
Cell Mol Life Sci. 2002 Sep;59(9):1534-53
pubmed: 12440774
Cardiovasc Res. 2008 Apr 1;78(1):158-66
pubmed: 18093987
Mol Cell Biol. 2008 May;28(9):2860-71
pubmed: 18299389
Oncogene. 2003 Nov 20;22(52):8460-71
pubmed: 14627987

Auteurs

Gabriel Alves Bonafé (GA)

Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Post Graduate Program in Health Science, São Francisco University (USF), Avenida São Francisco de Assis, 218, Bragança Paulista 12916-900, São Paulo, Brazil.
Laboratory of Human and Medical Genetics, Post Graduate Program in Health Science, USF, Bragança Paulista 12916-900, São Paulo, Brazil.

Jéssica Silva Dos Santos (JS)

Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Post Graduate Program in Health Science, São Francisco University (USF), Avenida São Francisco de Assis, 218, Bragança Paulista 12916-900, São Paulo, Brazil.
Laboratory of Human and Medical Genetics, Post Graduate Program in Health Science, USF, Bragança Paulista 12916-900, São Paulo, Brazil.

Jussara Vaz Ziegler (JV)

Verdi Cosmetics LLC, Joanópolis 12980-000, São Paulo, Brazil.

Fernando Augusto Lima Marson (FAL)

Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Post Graduate Program in Health Science, São Francisco University (USF), Avenida São Francisco de Assis, 218, Bragança Paulista 12916-900, São Paulo, Brazil.
Laboratory of Human and Medical Genetics, Post Graduate Program in Health Science, USF, Bragança Paulista 12916-900, São Paulo, Brazil.

Thalita Rocha (T)

Postgraduate Program in Biomaterials and Regenerative Medicine, Faculty of Medical Sciences and Health, Pontifical Catholic University of São Paulo, Sorocaba 05014-901, São Paulo, Brazil.

Manoela Marques Ortega (MM)

Laboratory of Cell and Molecular Tumor Biology and Bioactive Compounds, Post Graduate Program in Health Science, São Francisco University (USF), Avenida São Francisco de Assis, 218, Bragança Paulista 12916-900, São Paulo, Brazil.
Laboratory of Human and Medical Genetics, Post Graduate Program in Health Science, USF, Bragança Paulista 12916-900, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH